We are live on ! Find out more
KYTX icon

Kyverna Therapeutics
KYTX

94 hedge funds and large institutions have $138M invested in Kyverna Therapeutics in 2024 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 21

14% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 22

7% more funds holding

Funds holding: 88 → 94 (+6)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

8.85% less ownership

Funds ownership: 74.08% → 65.22% (-8.9%)

42% less capital invested

Capital invested by funds: $240M → $138M (-$101M)

90% less call options, than puts

Call options by funds: $7K | Put options by funds: $67K

Holders
94
Holders Change
+6
Holders Change %
+6.82%
% of All Funds
1.35%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
27
Increased
25
Reduced
22
Closed
21
Calls
$7K
Puts
$67K
Net Calls
-$60K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$2.55M
2
JP Morgan Chase
JP Morgan Chase
New York
+$2.51M
3
MPM
MBB Public Markets
Illinois
+$1.57M
4
IHAM
Integral Health Asset Management
New York
+$1.54M
5
Franklin Resources
Franklin Resources
California
+$878K

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$13.9M
2
DM
Deerfield Management
New York
-$8.2M
3
CC
Casdin Capital
New York
-$4.31M
4
GPP
Great Point Partners
Connecticut
-$3.74M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$655K +$720K +93,447 +231%
Two Sigma Investments
27
Two Sigma Investments
New York
$601K -$258K -33,442 -21%
Ameriprise
28
Ameriprise
Minnesota
$600K +$36.9K +4,786 +4%
AAA
29
Affinity Asset Advisors
New York
$586K -$618K -80,100 -40%
Morgan Stanley
30
Morgan Stanley
New York
$586K +$3.94K +511 +0.4%
UBS AM
31
UBS AM
Illinois
$498K -$104K -13,465 -12%
TD Asset Management
32
TD Asset Management
Ontario, Canada
$472K – – –
Goldman Sachs
33
Goldman Sachs
New York
$390K +$135K +17,513 +28%
Barclays
34
Barclays
United Kingdom
$343K +$95.7K +12,418 +22%
CSS
35
Cubist Systematic Strategies
Connecticut
$337K +$532K +68,958 New
XT
36
XTX Topco
Cayman Islands
$258K -$235K -30,494 -37%
Hudson Bay Capital Management
37
Hudson Bay Capital Management
Connecticut
$254K +$401K +52,035 New
Alyeska Investment Group
38
Alyeska Investment Group
Illinois
$220K -$347K -45,000 -50%
Verition Fund Management
39
Verition Fund Management
Connecticut
$218K +$344K +44,626 New
Bank of New York Mellon
40
Bank of New York Mellon
New York
$212K -$96.6K -12,524 -22%
WP
41
Woodline Partners
California
$208K -$697K -90,423 -68%
ECM
42
ExodusPoint Capital Management
New York
$205K +$324K +41,984 New
Norges Bank
43
Norges Bank
Norway
$196K -$1.08M -140,593 -78%
Prudential Financial
44
Prudential Financial
New Jersey
$193K +$305K +39,570 New
Jane Street
45
Jane Street
New York
$192K +$133K +17,215 +78%
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$185K – – –
DekaBank Deutsche Girozentrale
47
DekaBank Deutsche Girozentrale
Germany
$181K – – –
Point72 Asset Management
48
Point72 Asset Management
Connecticut
$169K +$266K +34,482 New
Balyasny Asset Management
49
Balyasny Asset Management
Illinois
$163K +$257K +33,308 New
AA
50
ALPS Advisors
Colorado
$162K -$4.42K -573 -2%
1
2
3 4 5

KYTX Hedge Fund Activity: Q3 2024 in Review

94 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Kyverna Therapeutics (KYTX) for Q3 2024, worth a combined $138M — down 42% from $240M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new KYTX positions and 21 closed out — a net gain of 6 holders — while 25 added to existing stakes and 22 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.55M. The largest seller was RTW Investments, exiting entirely with an estimated $13.9M sold.

  • 94 institutional investors held Kyverna Therapeutics (KYTX) as of Q3 2024, up from 88 in Q2 2024.
  • Funds reported $138M of Kyverna Therapeutics stock for Q3 2024, down 42% quarter-over-quarter.
  • 27 funds opened new Kyverna Therapeutics positions in Q3 2024 and 21 closed out, a net change of +6 holders.
  • The largest Kyverna Therapeutics buyer in Q3 2024 was Millennium Management, an estimated $2.55M added.
  • The largest Kyverna Therapeutics seller in Q3 2024 was RTW Investments, an estimated $13.9M sold.

Based on aggregated 13F filings for Q3 2024.